Muken Ross 4

4 · SOPHiA GENETICS SA · Filed Apr 21, 2026

AI-generated summary of this filing

Updated Apr 21, 2026

SOPHiA GENETICS (SOPH) President Muken Ross Sells 760 Shares

What Happened

Muken Ross, President of SOPHiA GENETICS SA (SOPH), sold 760 shares in an open‑market transaction on April 20, 2026. The weighted average price reported was $5.20 per share (range $5.10–$5.29), for a total reported value of $3,955. This was a sale (routine disposition), not a purchase.

Key Details

Transaction date: 2026-04-20; reported on Form 4 filed 2026-04-21 (timely filing).
Price: weighted average $5.20; individual trade prices ranged $5.10–$5.29 (Reporting Person can provide per‑price breakdown on request).
Shares sold: 760; total reported proceeds $3,955.
Shares owned after transaction: not provided in the information you supplied.
Footnotes: F1 — sale effected to satisfy tax withholding obligations from RSU vesting on April 18, 2026; F1 notes sales were executed under a pre-established Rule 10b5-1(c) plan and were non‑discretionary. F2 — price is weighted average; range provided.

Context

These shares were sold specifically to cover tax withholding on vested restricted stock units (RSUs), and were executed under a 10b5‑1 trading plan. Such tax‑related sales are generally routine and do not necessarily signal the insider’s view on the company’s stock.

Form 4

Period: 2026-04-20

DirectorChief Executive Officer

Transactions

Footnotes (2)

[F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
[F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.10 to $5.29, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Signature

/s/ Elimara Brunetto as Attorney-in-fact for Ross Muken|2026-04-21

1 file